BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12642005)

  • 1. Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related Lymphoma.
    Little RF; Wilson WH
    Curr Infect Dis Rep; 2003 Apr; 5(2):176-184. PubMed ID: 12642005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy.
    Vishnu P; Aboulafia DM
    Adv Hematol; 2012; 2012():485943. PubMed ID: 22400030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.
    Wyen C; Jensen B; Hentrich M; Siehl J; Sabranski M; Esser S; Gillor D; Müller M; Van Lunzen J; Wolf T; Bogner JR; Wasmuth JC; Christ H; Fätkenheuer G; Hoffmann C
    AIDS; 2012 Feb; 26(4):457-64. PubMed ID: 22112600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of AIDS-related non-Hodgkin's lymphomas.
    Kersten MJ; Van Oers RH
    Drugs; 2001; 61(9):1301-15. PubMed ID: 11511024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy.
    Barclay LR; Buskin SE; Kahle EM; Aboulafia DM
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):272-9. PubMed ID: 17324334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma.
    Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B
    Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on HIV lymphoma.
    Noy A
    Curr Oncol Rep; 2007 Sep; 9(5):384-90. PubMed ID: 17706167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma.
    Lim ST; Levine AM
    CA Cancer J Clin; 2005; 55(4):229-41; 260-1, 264. PubMed ID: 16020424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.
    Besson C; Goubar A; Gabarre J; Rozenbaum W; Pialoux G; Châtelet FP; Katlama C; Charlotte F; Dupont B; Brousse N; Huerre M; Mikol J; Camparo P; Mokhtari K; Tulliez M; Salmon-Céron D; Boué F; Costagliola D; Raphaël M
    Blood; 2001 Oct; 98(8):2339-44. PubMed ID: 11588028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update in HIV lymphoma.
    Noy A
    Curr Opin Oncol; 2006 Sep; 18(5):449-55. PubMed ID: 16894292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of HIV-related lymphoma.
    Irwin D; Kaplan L
    Curr Opin Oncol; 1993 Sep; 5(5):852-60. PubMed ID: 8218498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of AIDS-related lymphoma.
    Levine AM
    Curr Opin Oncol; 2008 Sep; 20(5):522-8. PubMed ID: 19106654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicpathological features and survival of patients with AIDS related non-Hodgkin's lymphoma].
    Sun KY; Gui XE; Deng D; Xiong Y; Deng LP; Gao SC; Zhang YX
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):97-101. PubMed ID: 28279031
    [No Abstract]   [Full Text] [Related]  

  • 17. Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.
    Tirelli U; Spina M; Jaeger U; Nigra E; Blanc PL; Liberati AM; Benci A; Sparano JA
    Recent Results Cancer Res; 2002; 159():149-53. PubMed ID: 11785839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
    Jazirehi AR; Bonavida B
    Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-Associated Malignant Lymphoma.
    Brunnberg U; Hentrich M; Hoffmann C; Wolf T; Hübel K
    Oncol Res Treat; 2017; 40(3):82-87. PubMed ID: 28253516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
    Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
    Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.